UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

Activity of tissue factor in microparticles produced in vitro by endothelial cells, monocytes, granulocytes, and platelets

Biochemistry (Moscow), 2016-02, Vol.81 (2), p.114-121

2016

Volltextzugriff (PDF)

Characteristics of a New DNA Aptamer, Direct Inhibitor of Thrombin

Bulletin of experimental biology and medicine, 2011-02, Vol.150 (4), p.422-425

2011

Volltextzugriff (PDF)

DNA Aptamers to Thrombin Exosite I. Structure-Function Relationships and Antithrombotic Effects

Biochemistry (Moscow), 2019-12, Vol.84 (12-13), p.1521-1528

2019

Volltextzugriff (PDF)

Inhibition of Thrombin Activity with DNA-Aptamers

Bulletin of experimental biology and medicine, 2009-07, Vol.148 (1), p.33-36

2009

Volltextzugriff (PDF)

The fibrinolysis system: regulation of activity and physiologic functions of its main components

Biochemistry (Moscow), 2002-01, Vol.67 (1), p.99-108

2002

Volltextzugriff (PDF)

Effect of fibrinogen on platelet reactivity measured by the VerifyNow P2Y12 assay

Biochemistry (Moscow), 2016-05, Vol.81 (5), p.439-444

2016

Volltextzugriff (PDF)

Renal function in patients receiving long-term warfarin therapy: A five-year prospective follow-up

Terapevtic̆eskii arhiv, 2017, Vol.89 (9), p.78

2017

Volltextzugriff (PDF)

HAS-BLED and HEMORR2HAGES Scales in Assessment of Bleeding Risk in Patients on Long-Term Warfarin Therapy

Kardiologiia, 2015-01, Vol.55 (9), p.50

2015

Volltextzugriff (PDF)

High plasma D-dimer and von Willebrand factor levels are associated with risk of upper gastrointestinal bleeding in patients with chronic coronary syndromes receiving long-term antiplatelet therapy

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

P5587Elevated D-dimer level after 1 month anticoagulant therapy as a predictor for adverse outcomes in patients with venous thromboembolism: 10-year follow-up results

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease

Terapevtic̆eskii arhiv, 2023-11, Vol.95 (9), p.763

2023

Volltextzugriff (PDF)

Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage

Terapevtic̆eskii arhiv, 2011-01, Vol.83 (6), p.59

2011

Volltextzugriff (PDF)

351TAFI level dynamics during long-term warfarin therapy as a predictor of recurrent bleedings in a target INR

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

D-dimer and platelet aggregability are related to thrombotic events in patients with peripheral arterial occlusive disease

European heart journal, 2002-08, Vol.23 (16), p.1309-1316

2002

Volltextzugriff (PDF)

Prolongation of enoxaparin therapy to one month promotes recanalization of the occlusively thrombosed deep veins

Terapevtic̆eskii arhiv, 2011-01, Vol.83 (8), p.33

2011

Volltextzugriff (PDF)

Clopidogrel resistance in patients with acute coronary syndrome

Terapevtic̆eskii arhiv, 2010-01, Vol.82 (8), p.14

2010

Volltextzugriff (PDF)

Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications

Terapevtic̆eskii arhiv, 2011-01, Vol.83 (12), p.43

2011

Volltextzugriff (PDF)

D-dimer testing during anticoagulant therapy should be used to indicate patients who need extended anticoagulant therapy

European heart journal, 2013-08, Vol.34 (suppl 1), p.1080-1080

2013

Volltextzugriff (PDF)

Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment

Terapevtic̆eskii arhiv, 2009-01, Vol.81 (9), p.57

2009

Volltextzugriff (PDF)

Effect of fibrinogen on platelet reactivity measured by the VerifyNow P2Y^sub 12^ assay

Biochemistry (Moscow), 2016-05, Vol.81 (5), p.439

2016

Volltextzugriff (PDF)

Low doses of activated protein C delay arterial thrombosis in rats

Thrombosis research, 1990-02, Vol.57 (4), p.645-650

1990

Volltextzugriff (PDF)

UROKINASE PLASMINOGEN ACTIVATOR SYSTEM IN HUMANS WITH STABLE CORONARY ARTERY DISEASE

Clinical and experimental pharmacology & physiology, 1999-04, Vol.26 (4), p.354-357

1999

Volltextzugriff (PDF)

Capital in Manufacturing and Mining: Its Formation and Financing

1, 2015

Volltextzugriff (PDF)

Effect of therapy with clopidogrel on walking tolerance and parameters of hemostasis in patients with atherosclerosis of lower extremities and intermittent claudication

Kardiologiia, 2002, Vol.42 (3), p.45

2002

Volltextzugriff (PDF)

Anticoagulant action and safety of warfarin dosing based on pharmacogenetic testing: results of the first Russian prospective pilot study

Kardiologiia, 2010, Vol.50 (5), p.42

2010

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Englisch
(105)
Russisch
(29)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activity of tissue factor in microparticles produced in vitro by endothelial cells, monocytes, granulocytes, and platelets

Characteristics of a New DNA Aptamer, Direct Inhibitor of Thrombin

DNA Aptamers to Thrombin Exosite I. Structure-Function Relationships and Antithrombotic Effects

Inhibition of Thrombin Activity with DNA-Aptamers

The fibrinolysis system: regulation of activity and physiologic functions of its main components

Effect of fibrinogen on platelet reactivity measured by the VerifyNow P2Y12 assay

Renal function in patients receiving long-term warfarin therapy: A five-year prospective follow-up

HAS-BLED and HEMORR2HAGES Scales in Assessment of Bleeding Risk in Patients on Long-Term Warfarin Therapy

High plasma D-dimer and von Willebrand factor levels are associated with risk of upper gastrointestinal bleeding in patients with chronic coronary syndromes receiving long-term antiplatelet therapy

P5587Elevated D-dimer level after 1 month anticoagulant therapy as a predictor for adverse outcomes in patients with venous thromboembolism: 10-year follow-up results

Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease

Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage

351TAFI level dynamics during long-term warfarin therapy as a predictor of recurrent bleedings in a target INR

D-dimer and platelet aggregability are related to thrombotic events in patients with peripheral arterial occlusive disease

Prolongation of enoxaparin therapy to one month promotes recanalization of the occlusively thrombosed deep veins

Clopidogrel resistance in patients with acute coronary syndrome

Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications

D-dimer testing during anticoagulant therapy should be used to indicate patients who need extended anticoagulant therapy

Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment

Effect of fibrinogen on platelet reactivity measured by the VerifyNow P2Y^sub 12^ assay

Low doses of activated protein C delay arterial thrombosis in rats

UROKINASE PLASMINOGEN ACTIVATOR SYSTEM IN HUMANS WITH STABLE CORONARY ARTERY DISEASE

Capital in Manufacturing and Mining: Its Formation and Financing

Effect of therapy with clopidogrel on walking tolerance and parameters of hemostasis in patients with atherosclerosis of lower extremities and intermittent claudication

Anticoagulant action and safety of warfarin dosing based on pharmacogenetic testing: results of the first Russian prospective pilot study

Suchergebnisse filtern